#Global Health7
Lenacapavir rollout in Zimbabwe faces diplomatic dispute
Zimbabwe has begun a phase one rollout of the long-acting HIV prevention drug lenacapavir. A diplomatic dispute with the US has put future doses at risk, and health officials warn that delays could cause drug resistance.
Photo by Radission US, Unsplash
Some low-cost glucometers read newborn glucose accurately
A Rice360 study tested commonly available point-of-care glucometers in the lab to see if low-cost models can measure newborn glucose safely. Several inexpensive meters gave reliable readings at neonatal ranges, offering options for low-resource hospitals.
2025 aid cuts threaten health and humanitarian services
Large reductions in international aid in 2025 disrupted health and humanitarian services in many low- and middle-income countries. The cuts began with a US suspension of aid and led to the closure of USAID and wider global impacts.
Western Pacific priorities as WHO adapts after US withdrawal
WHO regional director Saia Maʻu Piukala outlines challenges and priorities for the Western Pacific as the organisation adapts after the US withdrawal. Key events include the World Health Summit in Berlin (12–14 October) and the Fiji Regional Committee (20–24 October 2025).
No more articles